Clinical and neuroradiographic features of fentanyl inhalation-induced leukoencephalopathy

BMJ Case Rep. 2024 Apr 29;17(5):e258395. doi: 10.1136/bcr-2023-258395.

Abstract

A man in his late 40s with no known past medical history was unresponsive for an unknown period of time. Crushed pills and white residue were found on a nearby table. On presentation he was obtunded and unresponsive to verbal commands but withdrawing to painful stimuli. The initial urine drug screen was negative, but a urine fentanyl screen was subsequently positive with a level of 137.3 ng/mL. MRI of the brain showed reduced diffusivity and fluid attenuated inversion recovery (FLAIR) hyperintensity symmetrically in the bilateral supratentorial white matter, cerebellum and globus pallidus. Alternative diagnoses such as infection were considered, but ultimately the history and workup led to a diagnosis of fentanyl-induced leukoencephalopathy. Three days after admission the patient became able to track, respond to voice and follow basic one-step commands. The patient does not recall the mechanism of inhalation. While there are case reports of heroin-induced leukoencephalopathy following inhaled heroin use and many routes of fentanyl, this is the first reported case of a similar phenomenon due to fentanyl inhalation.

Keywords: Adult intensive care; Drug misuse (including addiction); Neuroimaging; Neurological injury; Toxicology.

Publication types

  • Case Reports

MeSH terms

  • Administration, Inhalation
  • Adult
  • Analgesics, Opioid / adverse effects
  • Brain / diagnostic imaging
  • Brain / drug effects
  • Fentanyl* / adverse effects
  • Humans
  • Leukoencephalopathies* / chemically induced
  • Leukoencephalopathies* / diagnostic imaging
  • Magnetic Resonance Imaging*
  • Male

Substances

  • Fentanyl
  • Analgesics, Opioid